Breaking News, Collaborations & Alliances

Hitachi Chemical Acquires apceth Biopharma

Hitachi nabs two state-of-the-art GMP/BSL2 production facilities including 600 square meters of cleanroom area

Hitachi Chemical Co. Ltd. has acquired apceth Biopharma GmbH. apceth Biopharma manufactures cell and gene therapy products for American and European clients through two manufacturing sites in Munich, Germany, certified for GMP manufacture since 2010. These facilities are fully compliant with all current EU regulations (ATMP regulation (EC) No.1394/2007) and ICH guidelines. Through this deal, Hitachi Chemical will acquire two state-of-the-art GMP/BSL2 production facilities including 600 m2 of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters